___

• • Amin, E., Dubey, B. N., Zhang, S. C., Gremer, L., Dvorsky, R., Moll, J. M., ... & Ahmadian, M. R. (2013). Rho-kinase: regulation, (dys) function, and inhibition. Biological Chemistry, 394(11): 1399–1410. doi:10.1515/hsz-2013-0181.
• • Bora, G., Sucularlı, C., Hensel, N., Claus, P., & Yurter, H. E. (2019). Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy. The Journal of Pediatric Research, 6(2), 148–154. doi: 10.4274/jpr.galenos.2019.71473
• • Bora, G., Koyunoğlu, D., Sunguroğlu, M., & Yurter, H. E. (2019). Microtubule Structure, Organization and Defects: Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Turkiye Klinikleri Journal of Medical Sciences, 39(2), 221–230. doi: 10.5336/medsci. 2018-63881
• • Brown, S. S., & Spudich, J. A. (1979). Nucleation of polar actin filament assembly by a positively charged surface. The Journal of Cell Biology, 80, 499-504. doi: 10.1083/jcb.80.2.499 • Brown, S. S., & Spudich, J. A. (1981). Mechanism of action of cytochalasin: evidence that it binds to actin filament ends. The Journal of Cell Biology, 88(3), 487–491. doi: 10.1083/jcb.88.3.487
• • Brunden, K. R., Yao, Y., Potuzak, J. S., Ferrer, N. I., Ballatore, C., James, M. J., …Lee, V. M. Y. (2011). The characterization of microtubulestabilizing drugs as possible therapeutic agents for Alzheimer’s disease and related tauopathies. Pharmacological Research, 63(4), 341–351. https://doi.org/10.1016/j.phrs.2010.12.002
• • Bryce, N. S., Hardeman, E. C., Gunning, P. W., & Lock, J. G. (2019). Chemical biology approaches targeting the actin cytoskeleton through phenotypic screening. Current Opinion in Chemical Biology, 51, 40–47. doi: 10.1016/j.cbpa.2019.02.013
• • Carlier, M. F. (2001). Faculty of 1000 evaluation for A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. F1000 - Post-Publication Peer Review of the Biomedical Literature. doi: 10.3410/f.1000267.14705
• • Chen, Y., & Hancock, W. O. (2015). Kinesin-5 is a microtubule polymerase. Nature Communications, 6(1). doi: 10.1038/ncomms9160 • Colchicine for Amyotrophic Lateral Sclerosis - Full Text View. (n.d.). Retrieved from https://clinicaltrials.gov/ct2/show/NCT03693781
• • Coluccio, L. M., & Tilney, L. G. (1984). Phalloidin enhances actin assembly by preventing monomer dissociation. Journal of Cell Biology, 99(2), 529–535. https://doi.org/10.1083/jcb.99.2.529
• • Currier, M. A., Stehn, J. R., Swain, A., Chen, D., Hook, J., Eiffe, E., … Cripe, T. P. (2017). Identification of Cancer-Targeted Tropomyosin Inhibitors and Their Synergy with Microtubule Drugs. Molecular Cancer Therapeutics, 16(8), 1555–1565. doi: 10.1158/1535-7163. mct-16-0873
• • Dalbeth, N., Lauterio, T. J., & Wolfe, H. R. (2014). Mechanism of action of colchicine in the treatment of gout. Clinical Therapeutics, 36(10), 1465–1479. https://doi.org/10.1016/j.clinthera.2014.07.017
• • Dubey, J., Ratnakaran, N., & Koushika, S. P. (2015). Neurodegeneration and microtubule dynamics: Death by a thousand cuts. Frontiers in Cellular Neuroscience, 9(September), 1–15. https://doi. org/10.3389/fncel.2015.00343
• • Engel, T., Goñi-Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006). (Engel et al., 2006) pre-formed neurofibrillary tangles do not revert. Journal of Neurochemistry, 99(6), 1445–1455. https://doi. org/10.1111/j.1471-4159.2006.04139.x
• • Evans, K. J., Gomes, E. R., Reisenweber, S. M., Gundersen, G. G., & Lauring, B. P. (2005). Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. Journal of Cell Biology 168, 599–606. https://doi.org/10.1083/jcb.200409058
• • Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., … Brábek, J. (2017). Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges. Trends in Cancer, 3(6), 391–406. https://doi.org/10.1016/j.trecan.2017.04.008
• • Grin, B., Mahammad, S., Wedig, T., Cleland, M. M., Tsai, L., Herrmann, H., & Goldman, R. D. (2012). Withaferin A alters intermediate filament organization, cell shape and behavior. PLoS ONE, 7(6), 1–13. https://doi.org/10.1371/journal.pone.0039065
• • Guo, W., Naujock, M., Fumagalli, L., Vandoorne, T., Baatsen, P., Boon, R., … Van Den Bosch, L. (2017). HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUSALS patients. Nature Communications, 8(1), 1–14. https://doi. org/10.1038/s41467-017-00911-y.
• • Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., … Weissenbach, J. (1999). Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nature Genetics, 23(3), 296–303. doi: 10.1038/15472
• • Janke, C., & Kneussel, M. (2010). Tubulin post-translational modifications: Encoding functions on the neuronal microtubule cytoskeleton. Trends in Neurosciences, 33(8), 362–372. https://doi. org/10.1016/j.tins.2010.05.001
• • Lee, J. J., & Swain, S. M. (2008). The epothilones: Translating from the laboratory to the clinic. Clinical Cancer Research, 14(6), 1618– 1624. https://doi.org/10.1158/1078-0432.CCR-07-2201
• • Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011). GSK-3 in neurodegenerative diseases. International Journal of Alzheimer’s Disease, 2011. https://doi.org/10.4061/2011/189246
• • Lodish, H., Berk, A., Matsudaira, P., Kaiser, C. A., Krieger, M., Scott, M. P., Zipursky, S. L., & Darnell, J. (2003). Molecular Cell Biology. New York: W. H. Freeman.
• • Nakashima, S., Matsuda, H., Kurume, A., Oda, Y., Nakamura, S., Yamashita, M., & Yoshikawa, M. (2010). Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. Bioorganic and Medicinal Chemistry Letters, 20(9), 2994–2997. https://doi.org/10.1016/j.bmcl.2010.02.062
• • Niel, E., & Scherrmann, J. M. (2006). Colchicine today. Joint Bone Spine, 73(6), 672–678. https://doi.org/10.1016/j.jbspin.2006.03.006
• • Overmoyer, B., Waintraub, S., Kaufman, P. A., Doyle, T., Moore, H., Modiano, M., … Demario, M. (2005). Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer. Journal of Clinical Oncology, 23(16_suppl), 778–778. doi: 10.1200/jco.2005.23.16_suppl.778
• • Palazzo, A., Ackerman, B., & Gundersen, G. G. (2003). Tubulin acetylation and cell motility. Nature, 421(6920), 230. https://doi. org/10.1038/421230a
• • Peterson, J. R., & Mitchison, T. J. (2002). Small molecules, big impact: A history of chemical inhibitors and the cytoskeleton. Chemistry and Biology, 9(12), 1275–1285. https://doi.org/10.1016/ S1074-5521(02)00284-3
• • Roossien, D. H., Miller, K. E., & Gallo, G. (2015). Ciliobrevins as tools for studying dynein motor function. Frontiers in Cellular Neuroscience, 9(JULY), 1–10. https://doi.org/10.3389/fncel.2015.00252
• • Sánchez, C., Pérez, M., & Avila, J. (2000). GSK3β-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. European Journal of Cell Biology, 79(4), 252–260. https://doi.org/10.1078/S0171-9335(04)70028-X
• • Schofield, A. V., Steels, R., & Bernard, O. (2012). Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration. Journal of Biological Chemistry, 287(52), 43620–43629. https://doi. org/10.1074/jbc.M112.394965
• • Selenica, M. L., Jensen, H. S., Larsen, A. K., Pedersen, M. L., Helboe, L., Leist, M., & Lotharius, J. (2007). Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. British Journal of Pharmacology, 152(6), 959–979. doi: 10.1038/sj.bjp.0707471
• • Steinmetz, M. O., & Prota, A. E. (2018). Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton. Trends in Cell Biology, 28(10), 776–792. https://doi.org/10.1016/j.tcb.2018.05.001
• • Trivedi, N., Marsh, P., Goold, R. G., Wood-Kaczmar, A., & Gordon- Weeks, P. R. (2005). Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons. Journal of Cell Science, 118(5), 993–1005. https:// doi.org/10.1242/jcs.01697
• • Trogden, K. P., Battaglia, R. A., Kabiraj, P., Madden, V. J., Herrmann, H., & Snider, N. T. (2018). An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells. Federation of American Societies for Experimental Biology Journal, 32(5), 2841–2854. https://doi.org/10.1096/fj.201700663R
• • Xu, W., Ge, Y., Liu, Z., & Gong, R. (2015). Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion. Journal of Biological Chemistry, 290(3), 1348–1363. https://doi.org/10.1074/jbc.M114.593830
• • Yee, L., Lynch, T., Villalona-Calero, M., Rizvi, N., Gabrail, N., Sandler, A., … Palmer, G. (2005). A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer. Journal of Clinical Oncology, 23(16_suppl), 7127–7127. doi: 10.1200/ jco.2005.23.16_suppl.7127
• • Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., & Kaibuchi, K. (2005). GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell, 120(1), 137–149. https://doi. org/10.1016/j.cell.2004.11.012
• • Zemer, D., Pras, M., Sohar, E., Modan, M., Cabili, S., & Gafni, J. (1986). Colchicine in the prevention and treatment of the amyloidosis of Familial Mediterranean fever. The New England Journal of Medicine, 314, 1001-1005. doi:10.1056/NEJM198604173141601
• • Zhang, B., Carroll, J., Trojanowski, J. Q., Yao, Y., Iba, M., Potuzak, J. S., … Brunden, K. R. (2012). The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice. Journal of Neuroscience, 32(11), 3601–3611. doi: 10.1523/jneurosci.4922-11.2012
• • Zigmond, S. H. (2000). How Wasp Regulates Actin Polymerization. The Journal of Cell Biology, 150(6). doi: 10.1083/jcb.150.6.f117
• • Zumbrunn, J., Kinoshita, K., Hyman, A. A., & Näthke, I. S. (2001). Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation. Current Biology, 11(1), 44–49. doi: 10.1016/s0960-9822(01)00002-1.